Jones KL. In: Smith DA, ed. Smith's Recognizable Patterns of Human Malformation. 4th ed. Philadelphia, PA: WB Saunders Co; 1982:170-171.
2.
Mascari MJ, Gottlieb W., Rogan PK, et al. The frequency of uniparental disomy in Prader-Willi syndrome . N Engl J Med.1992;326:1599-1607.
3.
Ruvalcaba Rha , Holm VAEffects of growth hormone in Prader-Willi syndrome: a case report. Clin Pediatr.1993 ;32:292-295.
4.
Lee Pdk, Wilson DM, Hintz RL, Rosenfeld RGGrowth hormone treatment of short stature in Prader-Willi syndrome . Am J Med Genet.1987;28:865-871.
5.
Raiti S., Trias E., Levitsky L., Grossman MSOxandrolone and growth hormone: comparison of growth-stimulating effects in short children. Am J Dis Child.1973;126:597-600.
6.
Costeff H., Holm VA, Ruvalcaba R., Shaver J.Growth hormone secretion in Prader-Willi syndrome. Acta Paediatr Scand.1990;79:1059-1062.
7.
Walker JM, Bond SA, Voss LD, et al. Treatment of short normal children with growth hormone — a cautionary tale?Lancet. 1990;336:1331-1334.
8.
Torrado C., Bastian W., Wisniewski KE, Castells S.Treatment of children with Down syndrome and growth retardation with recombinant human growth hormone. J Pediatr.1991;119(3):478-483.
9.
Rosenfeld RGNonconventional growth hormone therapy in Turner syndrome: the United States experience. Horm Res. 1990;33:137-143.
10.
Underwood LE , Van Wyk JJ In: Wilson JD, Foster DW, eds. Williams Textbook of Endocrinology. 8th ed. Philadelphia, PA: WB Saunders Co; 1992;21:1123-1124.
11.
Albertsson-Wikland K., Karlberg J.Effect of GH treatment in short children on the timing of puberty and final height. Horrn Res.1991;35(suppl2):32.